Iran Pharmaceuticals & Healthcare Q4 2006

Published by: Business Monitor International

Published: Nov. 1, 2006 - 57 Pages

Table of Contents

Chapter 1 - Executive Summary

Iran Pharmaceuticals & Healthcare Industry SWOT

Iran Economic Industry SWOT

Iran Business Environment SWOT

Iran: Business Environment Ranking

Table: Business Environment Ranking: Middle East & Africa

Business Environment Ranking

Chapter 2 - Market Summary

Chapter 3 - Regulatory Regime

Intellectual Property

Pricing & Reimbursement

Chapter 4 - Industry Developments

Healthcare Sector

Epidemiological Trends

Pharmaceutical Industry

International Co-operation

Company Activity

Chapter 5 - Industry Forecast Scenario

Table: Iran Drug Expenditure Forecasts

Table: Economic Activity

Prescription & OTC Market Forecast

Table: OTC Market Forecasts

Table: Prescription Market Forecasts

Generics Market Forecast

Table: Generics Market Forecasts

Import/Export Market Forecast

Other Healthcare Data Forecasts

Table - Iran Healthcare Forecasts

Chapter 6 - Country Snapshot: Iran Demographic Data

Section 1: Population:

Table: Demographic Indicators (2005)

Table: Rural/Urban Breakdown

Section 2: Education & Healthcare

Table: Education

Table: Healthcare: Vital Statistics

Table: Healthcare: Expenditure

Section 3: Labour Market And Spending Power

Table: Employment Indicators

Table: Consumption and Stratification

Table: Wages per year

Chapter 7 - Competitive Landscape

Company Profiles

Iran Pharmaceuticals & Healthcare Report Q3 2006

Darou Pakhsh

Iran Pharmaceutical Development & Investment Company (IPDIC)

Pars Darou

Pharmieco

Chapter 8 - BMI Forecast Modelling

How we generate our industry forecasts

Pharmaceutical Industry

Sources

Chapter 9 - Appendix: Regional Demographic Data

The Long View: Data Over The Economic Cycle (2000-2007)

Population

Household Spending Per Capita, US$

Private Consumption Per Capita, US$ PPP

Market Size, GDP, US$bn

Abstract

Iran has a large and predominantly young population, which should be instrumental in driving the expansion of the pharmaceutical market over the coming years. BMI expects the value of the drug market to reach US$1.93bn by 2010. Drug prices, which are still among the lowest in the region, are rising as domestic companies seek to boost revenue. Domestic output accounted for around 90% of the country's requirements in 2005.

Government support for privatisation should also help the drug market improve, whilst making local manufacturers more efficient. All state-owned companies that import medicines are required to be privatised and terminate their activities by March 2007. In the past, all drug imports came through four state-owned companies, with local distribution undertaken by six government firms. At present, foreign drugmakers can import drugs through local offices, although the government still greatly favours local producers. All drug imports have to be approved by the Ministry of Health (MoH).

BMI's adjusted Business Environment Rankings for the Middle East & Africa reveal that Iran is in 12th place, ahead only of Nigeria and Zimbabwe. This is primarily due to political and economic uncertainty in the country, coupled with poor intellectual property standards. However, Iran's market is experiencing robust growth, although the dominant position of local manufacturing provides a substantial obstacle to investment.

Iranian drug exports are growing, led by demand from close regional neighbours. Two markets that are increasing in importance are Iraq and Afghanistan as these countries' economies begin to slowly recover from the effects of war. Afghanistan is currently Iran's largest drug export partner. Local player Iran Pharmaceutical Development and Investment Company IPDC) has yet to see sales return to pre-war levels. Future export growth will concentrate on the former Soviet sates in Central Asia, and the potentially lucrative African market. Meanwhile, Oman and Iran are planning to increase their co-operation in the field of healthcare, which could see a rise in exports from Iran to Oman.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.